Get Professional Valuation and Credit Risk Reports of Any Company in the World
New AI-Powered Free Company Valuation tool for any company in the world. Upload a PDF financial statement to receive an instant report with customizable forecasts, credit score, default probability and key financial metrics. Try Now for Free →
Get Professional Valuation and Credit Risk Reports of Any Company in the World
- Get an AI-powered company valuation or credit risk report in just 2 minutes
- Get reports of any company in the world with a financial statement in any language
- Upload a PDF financial statement to receive an instant report with customizable forecasts, credit score, default probability and key financial metrics
ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S — Credit Rating and Financial Key Figures
CVR number: 32323502
Tuborg Boulevard 12, 2900 Hellerup
Income statement (kEUR)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -6.05 | -8 328.99 | -44 611.00 | 22 097.00 | 5 567.00 |
| Costs of management | -88.04 | -89.54 | -8.00 | -11.00 | -2.00 |
| EBIT | -94.08 | -8 418.53 | -44 619.00 | 22 086.00 | 5 565.00 |
| Other financial income | 365.05 | 320.75 | 202.00 | 114.00 | |
| Other financial expenses | -0.08 | -0.35 | - 136.00 | -1 909.00 | -3 839.00 |
| Net income from associates (fin.) | -14 374.00 | -8 488.00 | |||
| Pre-tax profit | 270.89 | -8 098.13 | -44 553.00 | 5 917.00 | -6 762.00 |
| Income taxes | -57.87 | 8.41 | 62.00 | - 916.00 | 1 524.00 |
| Net earnings | 213.02 | -8 089.72 | -44 491.00 | 5 001.00 | -5 238.00 |
Assets (kEUR)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Participating interests | 13 575.00 | 9 201.00 | |||
| Investments total | 13 575.00 | 9 201.00 | |||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 52.00 | 30.00 | |||
| Current amounts owed by group member comp. | 14 798.86 | ||||
| Prepayments and accrued income | 1 059.76 | ||||
| Current other receivables | 5.66 | 5 661.99 | |||
| Short term receivables total | 14 804.52 | 6 721.75 | 52.00 | 30.00 | |
| Cash and bank deposits | 17.06 | 11.63 | 8.00 | 102.00 | |
| Cash and cash equivalents | 17.06 | 11.63 | 8.00 | 102.00 | |
| Balance sheet total (assets) | 14 821.58 | 6 733.38 | 8.00 | 13 729.00 | 9 231.00 |
Equity and liabilities (kEUR)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 134.04 | 134.04 | 134.00 | 134.00 | 134.00 |
| Shares repurchased | -8 089.72 | ||||
| Other reserves | 8 089.72 | 880.00 | - 636.00 | ||
| Retained earnings | 14 467.17 | 14 680.18 | 6 590.00 | -37 900.00 | -32 899.00 |
| Profit of the financial year | 213.02 | -8 089.72 | -44 491.00 | 5 001.00 | -5 238.00 |
| Shareholders equity total | 14 814.23 | 6 724.51 | -37 767.00 | -31 885.00 | -38 639.00 |
| Non-current owed to group member | 37 764.00 | 45 600.00 | 47 862.00 | ||
| Non-current liabilities total | 37 764.00 | 45 600.00 | 47 862.00 | ||
| Current trade creditors | 11.00 | 14.00 | 8.00 | ||
| Short-term deferred tax liabilities | 8.88 | ||||
| Other non-interest bearing current liabilities | 7.36 | ||||
| Current liabilities total | 7.36 | 8.88 | 11.00 | 14.00 | 8.00 |
| Balance sheet total (liabilities) | 14 821.58 | 6 733.38 | 8.00 | 13 729.00 | 9 231.00 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.